Overview

Brexpiprazole in Patients With Schizophrenia

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of brexpiprazole during long-term treatment.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Collaborator:
Otsuka Pharmaceutical Co., Ltd.
Treatments:
Brexpiprazole